Levitating Levetiracetam's Status for Status Epilepticus
نویسندگان
چکیده
منابع مشابه
Status epilepticus and refractory status epilepticus management.
Status epilepticus (SE) describes persistent or recurring seizures without a return to baseline mental status and is a common neurologic emergency. SE can occur in the context of epilepsy or may be symptomatic of a wide range of underlying etiologies. The clinician's aim is to rapidly institute care that simultaneously stabilizes the patient medically, identifies and manages any precipitant con...
متن کاملPharmacotherapy for Status Epilepticus
Status epilepticus (SE) represents the most severe form of epilepsy. It is one of the most common neurologic emergencies, with an incidence of up to 61 per 100,000 per year and an estimated mortality of 20 %. Clinically, tonic-clonic convulsive SE is divided into four subsequent stages: early, established, refractory, and super-refractory. Pharmacotherapy of status epilepticus, especially of it...
متن کاملStatus epilepticus.
PURPOSE OF REVIEW This review presents the state of the art in the diagnosis and management of status epilepticus. RECENT FINDINGS In addition to general background, this article presents the most recent findings regarding the diagnosis and treatment of status epilepticus, including the results of the Rapid Anticonvulsant Medication Prior to Arrival Trial (RAMPART) and the available data on t...
متن کاملStatus Epilepticus
Status epilepticus is defined as continuous seizure activity for greater than 5 minutes or consecutive seizures without regaining consciousness over 5 minutes. Status epilepticus is common in the epilepsy population and is often associated with acute, severe neurological injury or illness such as traumatic brain injury (TBI), intracerebral hemorrhage (ICH), meningitis, or pharmacologic toxicity...
متن کاملStatus epilepticus.
Status epilepticus (SE) is a neurological emergency resulting from prolonged Clinical or electroencephalographic seizure activity. Refractory SE refers to the persistence of seizure activity despite the initiation of first- and second-line anticonvulsant therapy. Sinister outcomes are often attributed to the etiology of SE. Despite randomized multicentre trials of established and promising ther...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Epilepsy Currents
سال: 2008
ISSN: 1535-7597,1535-7511
DOI: 10.1111/j.1535-7511.2008.00266.x